Altium Capital Management LP Igm Biosciences, Inc. Transaction History

Altium Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$27.59 - $66.39 $1.17 Million - $2.82 Million	-42,473 Closed	0 $0
Q3 2021 Nov 17, 2021	BUY	$65.76 - $90.65 $2.16 Million - $2.98 Million	32,920 Added 344.6%	42,473 $2.79 Million
Q3 2021 Nov 15, 2021	SELL	$65.76 - $90.65 $2.16 Million - $2.98 Million	-32,920 Reduced 77.51%	9,553 $430,000
Q2 2021 Aug 13, 2021	BUY	$57.98 - $96.6 $2.46 Million - $4.1 Million	42,473 New	42,473 $3.53 Million

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.